F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Fibrosis

1	Immunoglobulin G4-related disease in the sigmoid colon in patient with severe colonic fibrosis and obstruction: A case report 10/25/2022 11:36:14 AM \| Browse: 232 \| Download: 452
2	Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease 8/26/2022 9:51:35 AM \| Browse: 239 \| Download: 379
3	Use of shear wave elastography for the diagnosis and follow-up of biliary atresia: A meta-analysis 8/26/2022 7:50:06 AM \| Browse: 214 \| Download: 352
4	Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China 7/18/2022 9:47:46 AM \| Browse: 325 \| Download: 1253
5	Anabolic androgenic steroid-induced liver injury: An update 7/13/2022 7:30:59 AM \| Browse: 278 \| Download: 446
6	Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease 4/30/2022 5:08:22 AM \| Browse: 294 \| Download: 649
7	Application of artificial intelligence in non-alcoholic fatty liver disease and viral hepatitis 4/29/2022 11:12:04 AM \| Browse: 358 \| Download: 523
8	Loss of LAT1 sex-dependently delays recovery after caerulein-induced acute pancreatitis 3/11/2022 9:47:59 AM \| Browse: 352 \| Download: 616
9	Anti-fibrotic effect of adipose-derived stem cells on fibrotic scars 2/25/2022 12:19:16 PM \| Browse: 345 \| Download: 633
10	Correlation of hepatitis B surface antigen expression with clinicopathological and biochemical parameters in liver biopsies: A comprehensive study 1/21/2022 8:16:14 AM \| Browse: 326 \| Download: 599
11	Liver function tests and metabolic-associated fatty liver disease: Changes in upper normal limits, does it really matter? 12/27/2021 5:24:00 AM \| Browse: 267 \| Download: 402
12	De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation 12/27/2021 5:24:00 AM \| Browse: 320 \| Download: 468
13	Multiparameter magnetic resonance imaging of liver fibrosis in a bile duct ligation mouse model 12/17/2021 8:56:01 AM \| Browse: 434 \| Download: 979
14	Application of adipose-derived stem cells in treating fibrosis 11/25/2021 8:31:20 AM \| Browse: 321 \| Download: 462
15	Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit? 10/20/2021 7:18:39 AM \| Browse: 269 \| Download: 334
16	Artificial intelligence for hepatitis evaluation 9/9/2021 6:46:56 AM \| Browse: 468 \| Download: 724
17	Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist? 9/7/2021 8:15:21 AM \| Browse: 471 \| Download: 509
18	Clinical perspectives, assessment, and mechanisms of metabolic associated fatty liver disease in patients with COVID-19 9/3/2021 11:45:55 AM \| Browse: 433 \| Download: 645
19	Impact of donor-specific antibodies on long-term graft survival with pediatric liver transplantation 6/23/2021 1:49:40 AM \| Browse: 583 \| Download: 666
20	Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand? 3/18/2021 10:54:40 AM \| Browse: 563 \| Download: 748
21	Histopathological evaluation of long-term tenofovir disoproxil fumarate treatment in patients with hepatitis be antigen-negative chronic hepatitis B 3/18/2021 8:34:30 AM \| Browse: 472 \| Download: 896
22	Histopathology and predominantly progressive, indeterminate and predominately regressive score in hepatitis C virus patients after direct-acting antivirals therapy 1/29/2021 7:57:41 AM \| Browse: 526 \| Download: 1151
23	Autophagy in liver diseases 1/26/2021 4:22:54 PM \| Browse: 509 \| Download: 702
24	Obeticholic acid attenuates human immunodeficiency virus/alcohol metabolism-induced pro-fibrotic activation in liver cells 11/24/2020 12:41:21 PM \| Browse: 547 \| Download: 1245
25	Efficacy and safety of anti-hepatic fibrosis drugs 11/6/2020 7:36:12 AM \| Browse: 623 \| Download: 1278
26	Advances in the treatment of nonalcoholic steatohepatitis 10/29/2020 5:34:30 AM \| Browse: 775 \| Download: 1304
27	Periportal thickening on magnetic resonance imaging for hepatic fibrosis in infantile cholestasis 6/6/2020 2:43:56 PM \| Browse: 839 \| Download: 1373
28	Macrophages in metabolic associated fatty liver disease 4/28/2020 8:04:30 AM \| Browse: 724 \| Download: 922
29	Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma 1/16/2020 7:58:40 AM \| Browse: 764 \| Download: 1128
30	Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C 1/13/2020 11:27:12 AM \| Browse: 997 \| Download: 1180
31	Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source 9/7/2019 4:43:36 AM \| Browse: 855 \| Download: 1575
32	Layered enhancement at magnetic resonance enterography in inflammatory bowel disease: A meta-analysis 8/21/2019 9:19:18 AM \| Browse: 910 \| Download: 1416
33	Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease 7/28/2019 10:51:57 AM \| Browse: 726 \| Download: 799
34	Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets 7/6/2019 6:23:58 AM \| Browse: 1023 \| Download: 1560
35	Roles of hepatic stellate cells in acute liver failure: From the perspective of inflammation and fibrosis 5/27/2019 8:24:36 AM \| Browse: 790 \| Download: 1199
36	Effectiveness of venous thromboembolism prophylaxis in patients with liver disease 4/26/2019 3:40:00 AM \| Browse: 818 \| Download: 1136
37	Repurposing drugs to target nonalcoholic steatohepatitis 4/18/2019 5:48:09 AM \| Browse: 905 \| Download: 1106
38	Persistent elevation of fibrosis biomarker cartilage oligomeric matrix protein following hepatitis C virus eradication 3/27/2019 10:37:20 AM \| Browse: 1031 \| Download: 1816
39	Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus 3/20/2019 5:32:10 AM \| Browse: 1061 \| Download: 1698
40	Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice 3/20/2019 5:32:10 AM \| Browse: 1006 \| Download: 1160
41	Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects 2/26/2019 11:29:04 AM \| Browse: 981 \| Download: 1250
42	Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression 1/26/2019 11:40:14 AM \| Browse: 1200 \| Download: 1169
43	Correlation analysis of collagen proportionate area in Budd-Chiari syndrome: A preliminary clinicopathological study 1/26/2019 8:24:19 AM \| Browse: 783 \| Download: 1177
44	Current status, problems, and perspectives of non-alcoholic fatty liver disease research 1/14/2019 2:54:12 PM \| Browse: 1132 \| Download: 1340
45	Role of cenicriviroc in the management of nonalcoholic fatty liver disease 12/27/2018 8:56:32 AM \| Browse: 788 \| Download: 918
46	Management of local recurrence after endoscopic resection of neoplastic colonic polyps 12/21/2018 6:09:14 AM \| Browse: 873 \| Download: 1195
47	Liver as a target of human immunodeficiency virus infection 11/13/2018 8:04:45 AM \| Browse: 987 \| Download: 1198
48	Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer 10/18/2018 10:13:24 AM \| Browse: 920 \| Download: 1179
49	A small molecule fibrokinase inhibitor in a model of fibropolycystic hepatorenal disease 9/7/2018 9:21:44 AM \| Browse: 945 \| Download: 1389
50	Polycystic kidney and hepatic disease 1 gene mutations in von Meyenburg complexes: Case report 9/7/2018 1:56:18 AM \| Browse: 831 \| Download: 1137

Page 1 of 4 ( 159 items )
<<
1
2
3
4
>>

1	Immunoglobulin G4-related disease in the sigmoid colon in patient with severe colonic fibrosis and obstruction: A case report 10/25/2022 11:36:14 AM \| Browse: 232 \| Download: 452
2	Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease 8/26/2022 9:51:35 AM \| Browse: 239 \| Download: 379
3	Use of shear wave elastography for the diagnosis and follow-up of biliary atresia: A meta-analysis 8/26/2022 7:50:06 AM \| Browse: 214 \| Download: 352
4	Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China 7/18/2022 9:47:46 AM \| Browse: 325 \| Download: 1253
5	Anabolic androgenic steroid-induced liver injury: An update 7/13/2022 7:30:59 AM \| Browse: 278 \| Download: 446
6	Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease 4/30/2022 5:08:22 AM \| Browse: 294 \| Download: 649
7	Application of artificial intelligence in non-alcoholic fatty liver disease and viral hepatitis 4/29/2022 11:12:04 AM \| Browse: 358 \| Download: 523
8	Loss of LAT1 sex-dependently delays recovery after caerulein-induced acute pancreatitis 3/11/2022 9:47:59 AM \| Browse: 352 \| Download: 616
9	Anti-fibrotic effect of adipose-derived stem cells on fibrotic scars 2/25/2022 12:19:16 PM \| Browse: 345 \| Download: 633
10	Correlation of hepatitis B surface antigen expression with clinicopathological and biochemical parameters in liver biopsies: A comprehensive study 1/21/2022 8:16:14 AM \| Browse: 326 \| Download: 599
11	Liver function tests and metabolic-associated fatty liver disease: Changes in upper normal limits, does it really matter? 12/27/2021 5:24:00 AM \| Browse: 267 \| Download: 402
12	De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation 12/27/2021 5:24:00 AM \| Browse: 320 \| Download: 468
13	Multiparameter magnetic resonance imaging of liver fibrosis in a bile duct ligation mouse model 12/17/2021 8:56:01 AM \| Browse: 434 \| Download: 979
14	Application of adipose-derived stem cells in treating fibrosis 11/25/2021 8:31:20 AM \| Browse: 321 \| Download: 462
15	Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit? 10/20/2021 7:18:39 AM \| Browse: 269 \| Download: 334
16	Artificial intelligence for hepatitis evaluation 9/9/2021 6:46:56 AM \| Browse: 468 \| Download: 724
17	Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist? 9/7/2021 8:15:21 AM \| Browse: 471 \| Download: 509
18	Clinical perspectives, assessment, and mechanisms of metabolic associated fatty liver disease in patients with COVID-19 9/3/2021 11:45:55 AM \| Browse: 433 \| Download: 645
19	Impact of donor-specific antibodies on long-term graft survival with pediatric liver transplantation 6/23/2021 1:49:40 AM \| Browse: 583 \| Download: 666
20	Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand? 3/18/2021 10:54:40 AM \| Browse: 563 \| Download: 748
21	Histopathological evaluation of long-term tenofovir disoproxil fumarate treatment in patients with hepatitis be antigen-negative chronic hepatitis B 3/18/2021 8:34:30 AM \| Browse: 472 \| Download: 896
22	Histopathology and predominantly progressive, indeterminate and predominately regressive score in hepatitis C virus patients after direct-acting antivirals therapy 1/29/2021 7:57:41 AM \| Browse: 526 \| Download: 1151
23	Autophagy in liver diseases 1/26/2021 4:22:54 PM \| Browse: 509 \| Download: 702
24	Obeticholic acid attenuates human immunodeficiency virus/alcohol metabolism-induced pro-fibrotic activation in liver cells 11/24/2020 12:41:21 PM \| Browse: 547 \| Download: 1245
25	Efficacy and safety of anti-hepatic fibrosis drugs 11/6/2020 7:36:12 AM \| Browse: 623 \| Download: 1278
26	Advances in the treatment of nonalcoholic steatohepatitis 10/29/2020 5:34:30 AM \| Browse: 775 \| Download: 1304
27	Periportal thickening on magnetic resonance imaging for hepatic fibrosis in infantile cholestasis 6/6/2020 2:43:56 PM \| Browse: 839 \| Download: 1373
28	Macrophages in metabolic associated fatty liver disease 4/28/2020 8:04:30 AM \| Browse: 724 \| Download: 922
29	Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma 1/16/2020 7:58:40 AM \| Browse: 764 \| Download: 1128
30	Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C 1/13/2020 11:27:12 AM \| Browse: 997 \| Download: 1180
31	Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source 9/7/2019 4:43:36 AM \| Browse: 855 \| Download: 1575
32	Layered enhancement at magnetic resonance enterography in inflammatory bowel disease: A meta-analysis 8/21/2019 9:19:18 AM \| Browse: 910 \| Download: 1416
33	Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease 7/28/2019 10:51:57 AM \| Browse: 726 \| Download: 799
34	Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets 7/6/2019 6:23:58 AM \| Browse: 1023 \| Download: 1560
35	Roles of hepatic stellate cells in acute liver failure: From the perspective of inflammation and fibrosis 5/27/2019 8:24:36 AM \| Browse: 790 \| Download: 1199
36	Effectiveness of venous thromboembolism prophylaxis in patients with liver disease 4/26/2019 3:40:00 AM \| Browse: 818 \| Download: 1136
37	Repurposing drugs to target nonalcoholic steatohepatitis 4/18/2019 5:48:09 AM \| Browse: 905 \| Download: 1106
38	Persistent elevation of fibrosis biomarker cartilage oligomeric matrix protein following hepatitis C virus eradication 3/27/2019 10:37:20 AM \| Browse: 1031 \| Download: 1816
39	Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus 3/20/2019 5:32:10 AM \| Browse: 1061 \| Download: 1698
40	Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice 3/20/2019 5:32:10 AM \| Browse: 1006 \| Download: 1160
41	Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects 2/26/2019 11:29:04 AM \| Browse: 981 \| Download: 1250
42	Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression 1/26/2019 11:40:14 AM \| Browse: 1200 \| Download: 1169
43	Correlation analysis of collagen proportionate area in Budd-Chiari syndrome: A preliminary clinicopathological study 1/26/2019 8:24:19 AM \| Browse: 783 \| Download: 1177
44	Current status, problems, and perspectives of non-alcoholic fatty liver disease research 1/14/2019 2:54:12 PM \| Browse: 1132 \| Download: 1340
45	Role of cenicriviroc in the management of nonalcoholic fatty liver disease 12/27/2018 8:56:32 AM \| Browse: 788 \| Download: 918
46	Management of local recurrence after endoscopic resection of neoplastic colonic polyps 12/21/2018 6:09:14 AM \| Browse: 873 \| Download: 1195
47	Liver as a target of human immunodeficiency virus infection 11/13/2018 8:04:45 AM \| Browse: 987 \| Download: 1198
48	Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer 10/18/2018 10:13:24 AM \| Browse: 920 \| Download: 1179
49	A small molecule fibrokinase inhibitor in a model of fibropolycystic hepatorenal disease 9/7/2018 9:21:44 AM \| Browse: 945 \| Download: 1389
50	Polycystic kidney and hepatic disease 1 gene mutations in von Meyenburg complexes: Case report 9/7/2018 1:56:18 AM \| Browse: 831 \| Download: 1137